{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T07:29:45Z","timestamp":1785914985949,"version":"3.56.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T00:00:00Z","timestamp":1604966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"DOI":"10.3389\/fcimb.2020.595415","type":"journal-article","created":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T06:39:10Z","timestamp":1604990350000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Short-Course Treatment With Imipramine Entrapped in Squalene Liposomes Results in Sterile Cure of Experimental Visceral Leishmaniasis Induced by Antimony Resistant Leishmania donovani With Increased Efficacy"],"prefix":"10.3389","volume":"10","author":[{"given":"Sandip","family":"Mukherjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supratim","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souradeepa","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shantanabha","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Budhaditya","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syamal","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1073\/pnas.75.6.2959","article-title":"Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs","volume":"75","author":"Alving","year":"1978","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s13071-016-1467-8","article-title":"Imipramine alters the sterol profile in Leishmania amazonensis and increases its sensitivity to miconazole","volume":"9","author":"Andrade-Neto","year":"2016","journal-title":"Parasites Vectors"},{"key":"B3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.exppara.2006.07.002","article-title":"Leishmania major: immune response in BALB\/c mice immunized with stress-inducible protein 1 encapsulated in liposomes","volume":"115","author":"Badiee","year":"2007","journal-title":"Exp. Parasitol"},{"key":"B4","first-page":"301","article-title":"Optimizing efficacy of Amphotericin B through nanomodification","volume":"2","author":"Barratt","year":"2007","journal-title":"Int. J. Nanomed"},{"key":"B5","doi-asserted-by":"publisher","first-page":"7160","DOI":"10.4049\/jimmunol.174.11.7160","article-title":"Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis","volume":"174","author":"Basu","year":"2005","journal-title":"J. Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/0035-9203(77)90155-9","article-title":"The use of Pentostam liposomes in the chemotherapy of experimental leishmaniasis","volume":"71","author":"Black","year":"1977","journal-title":"Trans. R. Soc. Trop. Med. Hyg"},{"key":"B7","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1590\/0037-8682-0041-2016","article-title":"Antimonial drugs entrapped into phosphatidylserine liposomes: physicochemical evaluation and antileishmanial activity","volume":"49","author":"Borborema","year":"2016","journal-title":"Rev. da sociedade Bras. med Trop."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e2536","DOI":"10.1371\/journal.pntd.0002536","article-title":"Risk factors for visceral leishmaniasis relapse in immunocompetent patients following treatment with 20 mg\/kg liposomal amphotericin B (Ambisome) in Bihar, India","volume":"8","author":"Burza","year":"2014","journal-title":"PloS Negl. Trop. Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4103\/0974-777X.62863","article-title":"A current perspective on leishmaniasis","volume":"2","author":"Clem","year":"2010","journal-title":"J. Glob Infect. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.pt.2003.09.008","article-title":"Leishmaniasis\u2013current chemotherapy and recent advances in the search for novel drugs","volume":"19","author":"Croft","year":"2003","journal-title":"Trends Parasitol"},{"key":"B11","first-page":"399","article-title":"Current scenario of drug development for leishmaniasis","volume":"123","author":"Croft","year":"2006","journal-title":"Indian J. Med. Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin. Microbiol Rev."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00222-19","article-title":"Combination of Mycobacterium indicus pranii and Heat-Induced Promastigotes Cures Drug-Resistant Leishmania Infection: Critical Role of Interleukin-6-Producing Classical Dendritic Cells","volume":"88","author":"Dey","year":"2020","journal-title":"Infect. Immun."},{"key":"B14","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1128\/AAC.41.4.827","article-title":"In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis","volume":"41","author":"Faraut-Gambarelli","year":"1997","journal-title":"Antimicrob Agents Chemother."},{"key":"B15","article-title":"Imipramine","volume-title":"StatPearls","author":"Fayez","year":"2020"},{"key":"B16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1258\/002367790780890185","article-title":"The assessment and control of the severity of scientific procedures on laboratory animals","volume":"24","author":"Fiat","year":"1990","journal-title":"Lab. Anim."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.3390\/molecules14093286","article-title":"Squalene emulsions for parenteral vaccine and drug delivery","volume":"14","author":"Fox","year":"2009","journal-title":"Molecules"},{"key":"B18","volume-title":"Goodman and Gilman\u2019s the pharmacological basis of therapeutics","author":"Goodman","year":"1990"},{"key":"B19","first-page":"191","article-title":"Treatment of Mediterranean visceral leishmaniasis","volume":"73","author":"Gradoni","year":"1995","journal-title":"Bull. World Health Organ"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e2995","DOI":"10.1371\/journal.pntd.0002995","article-title":"Antimony resistant Leishmania donovani but not sensitive ones drives greater frequency of potent T-regulatory cells upon interaction with human PBMCs: role of IL-10 and TGF-\u03b2 in early immune response","volume":"8","author":"Guha","year":"2014","journal-title":"PloS Negl. Trop. Dis."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/571242","article-title":"Use of antimony in the treatment of leishmaniasis: current status and future directions","volume":"2011","author":"Haldar","year":"2011","journal-title":"Mol. Biol. Int."},{"key":"B22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0163-4453(94)95956-0","article-title":"Liposomal amphotericin B, AmBisome","volume":"28","author":"Hay","year":"1994","journal-title":"J. Infect."},{"key":"B23","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1248\/bpb1978.15.215","article-title":"Enhanced elimination of theophylline, phenobarbital and strychnine from the bodies of rats and mice by squalane treatment","volume":"15","author":"Kamimura","year":"1992","journal-title":"J. pharmacobio-dynamics"},{"key":"B24","doi-asserted-by":"publisher","first-page":"4490","DOI":"10.1002\/jps.23311","article-title":"AF03, an alternative squalene emulsion-based vaccine adjuvant prepared by a phase inversion temperature method","volume":"101","author":"Klucker","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/0005-2760(95)00005-W","article-title":"Kinetic study of quenching reaction of singlet oxygen and scavenging reaction of free radical by squalene in n-butanol","volume":"1256","author":"Kohno","year":"1995","journal-title":"Biochim. Biophys. Acta (BBA)-Lipids Lipid Metab."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.1021\/la981473a","article-title":"Use of a dynamic light scattering technique to study the kinetics of liposome solubilization by Triton X-100","volume":"15","author":"L\u00f3pez","year":"1999","journal-title":"Langmuir"},{"key":"B27","doi-asserted-by":"publisher","first-page":"9375","DOI":"10.1073\/pnas.0703678104","article-title":"Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy","volume":"104","author":"Lukes","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/617521","article-title":"Drug resistance in visceral leishmaniasis","volume":"2010","author":"Maltezou","year":"2010","journal-title":"J. BioMed. Biotechnol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.4049\/jimmunol.166.3.1912","article-title":"The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response","volume":"166","author":"Melby","year":"2001","journal-title":"J. Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e1987","DOI":"10.1371\/journal.pntd.0001987","article-title":"Imipramine is an orally active drug against both antimony sensitive and resistant Leishmania donovani clinical isolates in experimental infection","volume":"6","author":"Mukherjee","year":"2012","journal-title":"PloS Negl. Trop. Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.4049\/jimmunol.1400710","article-title":"Imipramine exploits histone deacetylase 11 to increase the IL-12\/IL-10 ratio in macrophages infected with antimony-resistant Leishmania donovani and clears organ parasites in experimental infection","volume":"193","author":"Mukherjee","year":"2014","journal-title":"J. Immunol."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.155245","article-title":"Probing the molecular mechanism of aggressive infection by antimony resistant Leishmania donovani","author":"Mukherjee","year":"2020","journal-title":"Cytokine 155245"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.ijpara.2011.07.013","article-title":"Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells","volume":"41","author":"Mukhopadhyay","year":"2011","journal-title":"Int. J. Parasitol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S1473-3099(05)70296-6","article-title":"Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in Indi","volume":"5","author":"Olliaro","year":"2005","journal-title":"Lancet Infect. Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"580","DOI":"10.4269\/ajtmh.2009.80.580","article-title":"Relapse of visceral leishmaniasis after miltefosine treatment in a Nepalese patient","volume":"80","author":"Pandey","year":"2009","journal-title":"Am. J. Trop. Med. Hyg"},{"key":"B36","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.biopha.2016.06.010","article-title":"High-throughput virtual screening and quantum mechanics approach to develop imipramine analogues as leads against trypanothione reductase of leishmania","volume":"83","author":"Pandey","year":"2016","journal-title":"Biomed pharmacother"},{"key":"B37","volume-title":"Nocturnal Enuresis: The Management of Bedwetting in Children and Young People","author":"PEOPLE","year":"2010"},{"key":"B38","doi-asserted-by":"publisher","first-page":"15160","DOI":"10.1021\/la302734r","article-title":"Chains, sheets, and droplets: assemblies of hydrophobic gold nanocrystals with saturated phosphatidylcholine lipid and squalene","volume":"28","author":"Rasch","year":"2012","journal-title":"Langmuir"},{"key":"B39","first-page":"168","article-title":"A simple and sensitive HPLC method for analysis of imipramine in human plasma with UV detection and liquid-liquid extraction: Application in bioequivalence studies","volume":"11","author":"Rezazadeh","year":"2016","journal-title":"Res. Pharm. Sci."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00353","article-title":"Sertraline Delivered in Phosphatidylserine Liposomes is Effective in Experimental Model of Visceral Leishmaniasis","volume":"9","author":"Romanelli","year":"2019","journal-title":"Front. Cell. infect Microbiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1176\/ajp.128.4.483","article-title":"The safety of a single daily dose schedule for imipramine","volume":"128","author":"Saraf","year":"1971","journal-title":"Am. J. Psychiatry"},{"key":"B42","first-page":"345","article-title":"Visceral leishmaniasis - current therapeutic modalities","volume":"123","author":"Sundar","year":"2006","journal-title":"Indian J. Med. Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/infdis\/173.3.762","article-title":"Cure of antimony-unresponsive Indian visceral leishmaniasis with amphotericin B lipid complex","volume":"173","author":"Sundar","year":"1996","journal-title":"J. Infect. Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1086\/318122","article-title":"Short-course of oral miltefosine for treatment of visceral leishmaniasis","volume":"31","author":"Sundar","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1086\/318121","article-title":"Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic","volume":"31","author":"Sundar","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1046\/j.1365-3156.2001.00778.x","article-title":"Drug resistance in Indian visceral leishmaniasis","volume":"6","author":"Sundar","year":"2001","journal-title":"Trop. Med. Int. Health"},{"key":"B47","first-page":"166","article-title":"Epidemiological, clinical & pharmacological study of antimony-resistant visceral leishmaniasis in Bihar, India","volume":"120","author":"Thakur","year":"2004","journal-title":"Indian J. Med. Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0304-4017(01)00389-2","article-title":"Long term improvement in the treatment of canine leishmaniosis using an antimony liposomal formulation","volume":"97","author":"Valladares","year":"2001","journal-title":"Vet parasitol"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2020.595415\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T06:39:14Z","timestamp":1604990354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2020.595415\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,10]]},"references-count":48,"alternative-id":["10.3389\/fcimb.2020.595415"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2020.595415","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,10]]},"article-number":"595415"}}